Literature DB >> 9535891

A chimeric protein C containing the prothrombin Gla domain exhibits increased anticoagulant activity and altered phospholipid specificity.

M D Smirnov1, O Safa, L Regan, T Mather, D J Stearns-Kurosawa, S Kurosawa, A R Rezaie, N L Esmon, C T Esmon.   

Abstract

To determine the structural basis of phosphatidylethanolamine (PE)-dependent activated protein C (APC) activity, we prepared a chimeric molecule in which the Gla domain and hydrophobic stack of protein C were replaced with the corresponding region of prothrombin. APC inactivation of factor Va was enhanced 10-20-fold by PE. Protein S enhanced inactivation 2-fold and independently of PE. PE and protein S had little effect on the activity of the chimera. Factor Va inactivation by APC was approximately 5-fold less efficient than with the chimera on vesicles lacking PE and slightly more efficient on vesicles containing PE. The cleavage patterns of factor Va by APC and the chimera were similar, and PE enhanced the rate of Arg506 and Arg306 cleavage by APC but not the chimera. APC and the chimera bound to phosphatidylserine:phosphatidylcholine vesicles with similar affinity (Kd approximately 500 nM), and PE increased affinity 2-3-fold. Factor Va and protein S synergistically increased the affinity of APC on vesicles without PE to 140 nM and with PE to 14 nM, but they were less effective in enhancing chimera binding to either vesicle. In a factor Xa one-stage plasma clotting assay, the chimera had approximately 5 times more anticoagulant activity than APC on PE-containing vesicles. Unlike APC, which showed a 10 fold dependence on protein S, the chimera was insensitive to protein S. To map the site of the PE and protein S dependence further, we prepared a chimera in which residues 1-22 were derived from prothrombin and the remainder were derived from protein C. This protein exhibited PE and protein S dependence. Thus, these special properties of the protein C Gla domain are resident outside of the region normally hypothesized to be critical for membrane interaction. We conclude that the protein C Gla domain possesses unique properties allowing synergistic interaction with factor Va and protein S on PE-containing membranes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9535891     DOI: 10.1074/jbc.273.15.9031

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Autolysis loop restricts the specificity of activated protein C: analysis by FRET and functional assays.

Authors:  Shabir H Qureshi; Chandrashekhara Manithody; Jong-Sup Bae; Likui Yang; Alireza R Rezaie
Journal:  Biophys Chem       Date:  2008-02-25       Impact factor: 2.352

Review 2.  Activated protein C action in inflammation.

Authors:  Pranita P Sarangi; Hyun-wook Lee; Minsoo Kim
Journal:  Br J Haematol       Date:  2009-12-08       Impact factor: 6.998

3.  Function of the activated protein C (APC) autolysis loop in activated FVIII inactivation.

Authors:  Thomas J Cramer; Andrew J Gale
Journal:  Br J Haematol       Date:  2011-04-04       Impact factor: 6.998

4.  Inhibition of APC anticoagulant activity on oxidized phospholipid by anti-{beta}2-glycoprotein I monoclonal antibodies.

Authors:  Omid Safa; Charles T Esmon; Naomi L Esmon
Journal:  Blood       Date:  2005-05-12       Impact factor: 22.113

5.  Phosphatidylethanolamine at the luminal endothelial surface--implications for hemostasis and thrombotic autoimmunity.

Authors:  Clive W Wells; Paula E North; Suresh Kumar; Christine B Duris; John A McIntyre
Journal:  Clin Appl Thromb Hemost       Date:  2009-11-10       Impact factor: 2.389

6.  Down-regulation of the clotting cascade by the protein C pathway.

Authors:  Fabian Stavenuiter; Eveline A M Bouwens; Laurent O Mosnier
Journal:  Hematol Educ       Date:  2013

7.  Functional properties and active-site topographies of factor X Gla- and prothrombin Gla-domain chimeras of activated protein C.

Authors:  Shabir H Qureshi; Likui Yang; Chandrashekhara Manithody; Jong-Sup Bae; Alireza R Rezaie
Journal:  Biochim Biophys Acta       Date:  2008-05-19

8.  Dissociation of activated protein C functions by elimination of protein S cofactor enhancement.

Authors:  Shona Harmon; Roger J S Preston; Fionnuala Ni Ainle; Jennifer A Johnson; Moya S Cunningham; Owen P Smith; Barry White; James S O'Donnell
Journal:  J Biol Chem       Date:  2008-09-08       Impact factor: 5.157

9.  A single-step kit formulation for the (99m)Tc-labeling of HYNIC-Duramycin.

Authors:  Ming Zhao; Zhixin Li
Journal:  Nucl Med Biol       Date:  2012-08-02       Impact factor: 2.408

10.  Modeling of human factor Va inactivation by activated protein C.

Authors:  Maria Cristina Bravo; Thomas Orfeo; Kenneth G Mann; Stephen J Everse
Journal:  BMC Syst Biol       Date:  2012-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.